Recurrent Metabolic Acidosis during High-dose Midazolam Therapy for Refractory Status Epilepticus.
Indian J Crit Care Med
; 22(2): 119-121, 2018 Feb.
Article
en En
| MEDLINE
| ID: mdl-29531455
ABSTRACT
High-dose continuous midazolam therapy has been used successfully for control of refractory status epilepticus. However, normal anion gap (AG) metabolic acidosis, a deleterious complication of this therapy is underrecognized. Even though previously reported in an isolated case report in a pediatric patient, we observed similar complication in an adult patient. Stereotyped normal AG metabolic acidosis along with hypotension developed on two occasions during high-dose continuous midazolam hydrochloride infusion that reverted rapidly following cessation of the infusion.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Indian J Crit Care Med
Año:
2018
Tipo del documento:
Article
País de afiliación:
India